Maximilian Schönung

13PUBLICATIONS
146CO-AUTHORS
AutoimmunityHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.

|Dec 05, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.

Mark Hartmann, Maximilian Schönung, Jovana Rajak

|Oct 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.

Yu-Yu Lin, Kersten Breuer, Dieter Weichenhan

|Jul 31, 2025
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study.

Maximilian Schönung, Silvia Rathmann, Senthilkumar Ramamoorthy

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Nov 21, 2022
DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.

Joschka Hey, Coral Halperin, Mark Hartmann

Pageof 3

Frequent Collaborators

12 joint publications

Daniel B Lipka

7 joint publications

Mark Hartmann

6 joint publications

Christoph Plass

5 joint publications

Matthias Schlesner